Immune modulatory interventions in people with HIV and cancer: prevention, treatment, and implications for HIV eradication. [ 2016 - ]

Research Grant

Researchers: Dr Mark Polizzotto (Principal investigator)

Brief description People with HIV are at increased risk of many cancers. New therapies that target the immune system may be useful in treating these cancers, and may also target the cells where HIV persists thereby assisting in eradication of HIV. This research program includes three clinical studies in people with HIV and cancer: one to learn more about their immunity; one to prevent, and one to treat certain cancers by modulating the immune system. Each also explores any effect on HIV eradication.

Funding Amount $344,644.00

Funding Scheme Early Career Fellowships

Notes Australian Clincal Research ECF